Table 5 Percentage of anti-malarial stocking private sector outlets with non-first-line anti-malarials available
Private for-profit health facility % (CI) | Pharmacy % (CI) | Drug store % (CI) | General retailer % (CI) | Itinerant drug vendor % (CI) | Private sector total % (CI) | |
|---|---|---|---|---|---|---|
Cambodia | N = 186 | N = 45 | N = 22 | N = 29 | N = 109 | N = 391 |
Second-line | 0.3 | 0.0 | 6.8 | 0.0 | 0.6 | 0.7 |
(0.1, 2.0) | – | (1.9, 21.4) | – | (0.1, 3.7) | (0.2, 2.2) | |
Not in NTGs | 12.8 | 16.3 | 45.3 | 100.0 | 48.4 | 34.0 |
(7.8, 20.4) | (9.0, 27.7) | (26.1, 66.1) | – | (38.2, 58.6) | (26.4, 42.5) | |
Lao PDR | N = 56 | N = 309 | N = 3 | N = 23 | N = 3 | N = 394 |
Second-line | 49.3 | 72.4 | 100.0 | 96.9 | 57.6 | 74.9 |
(33.7, 65.0) | (64.8, 78.9) | – | (83.0, 99.5) | (40.9, 72.8) | (68.6, 80.3) | |
Not in NTGs | 11.1 | 15.3 | 0.0 | 0.0 | 57.6 | 12.8 |
(5.4, 21.5) | (10.4, 21.9) | – | – | (40.9, 72.8) | (8.9, 18.2) | |
Myanmar | N = 314 | N = 522 | N/Aa | N = 1341 | N = 419 | N = 2596 |
Second-line | 15.6 | 27.2 | – | 6.2 | 46.9 | 19.8 |
(9.2, 21.9) | (20.8, 33.5) | (3.4, 9.0) | (40.7, 53.1) | (16.3, 23.3) | ||
Not in NTGs | 20.3 | 43.0 | – | 43.0 | 29.5 | 35.8 |
(13.8, 26.8) | (35.6, 50.4) | (36.7, 49.3) | (23.0, 36.0) | (31.6, 39.9) | ||
Thailand | N = 9 | N = 10 | N = 0 | N = 0 | N = 0 | N = 19 |
Second-line | 70.0 | 28.1 | – | – | – | 39.1 |
(23.8, 94.6) | (10.5, 56.7) | – | – | – | (19.6, 62.9) | |
Not in NTGs | 48.1 | 0.0 | – | – | – | 12.6 |
(13.7, 84.4) | – | – | – | – | (3.2, 38.6) |